Seite 1 von 15
Neuester Beitrag: 12.10.21 06:26
|Eröffnet am:||04.06.04 17:51||von: Biomedi||Anzahl Beiträge:||375|
|Neuester Beitrag:||12.10.21 06:26||von: Banani||Leser gesamt:||81.090|
|Seite: < 1 | 2 | 3 | 4 | 13 | 14 | 15 15 >|
Zahlen für Q2/21
These financial resources, combined with expected future non-dilutive funding under the current debt facility, are now expected to fund operations through the end of the first quarter of 2023.
“We are pleased with the achievement of 91% of the planned enrollment in IMerge Phase 3 and expect the trial to be fully enrolled in the fourth quarter of 2021. In addition, the expected timing for top-line results in IMerge Phase 3 has been accelerated by three months to the first quarter of 2023,”